Brain Cancer Treatment in Private Koru Ankara Hospital

Private Koru Ankara Hospital provides brain cancer diagnosis and treatment in Ankara, Turkey. Its JCI and SAS/ISQua accreditations accompany Gamma Knife radiosurgery and Elekta Versa HD radiotherapy. The hospital has 13 operating rooms and 71 intensive care beds.

Radiation oncologist Prof. Dr. Ali Aydın Yavuz has over 30 years of experience and trained at MD Anderson Cancer Center in 2008. Brain tumors are among his medical interests.

Brain cancer diagnostic tests

Imaging and tissue tests help assess brain tumors and guide treatment planning.

• High-field MRI: Includes diffusion, perfusion, MR angiography and MR spectroscopy.
• CT scan: Multi-slice CT supports cancer staging.
• PET-CT: Available through the hospital’s imaging and nuclear medicine services.
• Gamma Knife planning scans: MRI or CT images support treatment planning.
• Nuclear medicine scintigraphy: Available as an additional diagnostic test.
• Laboratory and pathology testing: Options include immunohistochemistry, FISH, PCR and next-generation sequencing.

Brain tumor treatment options

• Gamma Knife radiosurgery: Hundreds of focused gamma-ray beams target a lesion without open surgery. MRI or CT guides 3D planning with sub-millimeter accuracy. Treatment usually takes one session and can target deep or small lesions. Response is assessed over weeks to months.
• Microsurgical tumor removal: Surgeons remove benign or malignant tumors using a surgical microscope, endoscopic tools and intraoperative monitoring. Minimally invasive options are available, with intensive care support and planned rehabilitation.
• Neuronavigation-guided resection: Preoperative MRI or CT becomes a 3D model. Infrared cameras track instruments in real time, supporting access to deep lesions and gliomas in the dominant hemisphere.
• Pituitary tumor surgery: A transsphenoidal approach removes pituitary adenomas through the nasal corridor, avoiding open craniotomy.
• External beam radiotherapy: IMRT, IGRT and stereotactic radiosurgery are delivered using the Elekta Versa HD system. The total dose is divided into daily treatments to reduce side effects.
• Systemic therapy: Chemotherapy, immunotherapy, targeted therapy and hormone therapy may be considered for primary or metastatic brain tumors. Molecular profiling can include next-generation sequencing, liquid biopsy, TMB and MSI biomarkers.

Before surgery, a multidisciplinary council reviews each case. Tumor boards also discuss systemic treatment based on molecular findings, with neurology collaboration from diagnosis onward. The hospital holds JCI accreditation and SAS/ISQua Quality Accreditation, and has four dedicated neurosurgeons.

Patients can request a consultation through Bookimed to discuss available diagnostic and treatment options.